NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
Clinical Trials
72 trialsNCT07253220 2025-11-28
TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma
Sun Yat-sen University
Phase NA Not yet recruiting
NCT06084234 2025-11-26
TRACER
University of Texas Southwestern Medical Center
Phase 4 Recruiting
NCT05064553 2025-10-15
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Exact Sciences Corporation
Active not recruiting
NCT07079150 2025-07-22
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
First Affiliated Hospital Xi'an Jiaotong University
Recruiting
NCT06842563 2025-07-09
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
Singlera Genomics Inc.
Active not recruiting
NCT07038863 2025-06-26
Mondelta
Hospices Civils de Lyon
Phase NA Not yet recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT04000737 2025-04-13
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Yiviva Inc.
Phase 2 Completed
NCT06906016 2025-04-02
HBV-Biomark
Assistance Publique - Hôpitaux de Paris
Recruiting
NCT05195294 2025-03-10
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC
Lion TCR Pte. Ltd.
Phase 2 Not yet recruiting
NCT04710641 2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2 Completed
NCT05683548 2025-02-17
RCAP
Replicor Inc.
No longer available
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00059267 2024-11-15
Prevention of Recurrent Hepatitis B After Liver Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
NCT06629857 2024-10-08
A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in Pakistan
Darul Sehat Hospital
Completed
NCT01350648 2024-10-01
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
Completed
NCT05181826 2024-06-14
ELITE
Helio Genomics
Unknown
NCT05304234 2024-06-04
Liver Cancer Disparities in American Indian and Alaska Native Persons
University of Washington
Phase 2 Recruiting
NCT03887702 2024-05-20
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
SWOG Cancer Research Network
Phase 3 Terminated
NCT05823584 2024-04-10
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence
TCM Biotech International Corp.
Completed
NCT02366286 2023-12-14
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT03702998 2023-08-30
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Completed
NCT05752890 2023-03-03
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma
National Taiwan University Hospital
Not yet recruiting
NCT05716620 2023-02-08
Utility of Abbreviated Magnetic Resonance Imaging as a Screening Tool for Hepatocellular Carcinoma in Cirrhotic Patients
Post Graduate Institute of Medical Education and Research, Chandigarh
Unknown
NCT01970254 2022-08-15
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
M.D. Anderson Cancer Center
Completed
NCT05406089 2022-06-21
Effects of Antiviral Therapy on Patients With HBV-related HCC
First Affiliated Hospital Xi'an Jiaotong University
Completed
NCT03528941 2022-05-12
LLC1618
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT04659005 2022-04-06
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening
Chinese University of Hong Kong
Phase NA Completed
NCT02785835 2022-03-16
GEHEP-002
Hospital Universitario de Valme
Completed
NCT00013871 2021-11-01
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
National Institute of Allergy and Infectious Diseases (NIAID)
Phase NA Completed
NCT03221049 2021-09-02
Radiomics for Diagnosing Liver Diseases and Evaluating Progression
Third Affiliated Hospital, Sun Yat-Sen University
Unknown
NCT04317248 2020-10-29
"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown
NCT00342186 2020-06-16
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
National Institutes of Health Clinical Center (CC)
Completed
NCT04301908 2020-03-10
A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis
Beijing Ditan Hospital
Unknown
NCT04044651 2020-01-09
Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
Sun Yat-sen University
Phase 2/3 Withdrawn
NCT00637195 2020-01-03
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
GlaxoSmithKline
Phase 3 Completed
NCT02186574 2019-12-12
Tenofovir to Prevent HBV Reactivation
University Health Network, Toronto
Phase 3 Unknown
NCT04032392 2019-07-25
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
Beijing 302 Hospital
Phase 1 Unknown
NCT03680183 2018-09-28
Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Unknown
NCT01086709 2018-04-05
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
National Institutes of Health Clinical Center (CC)
Completed
NCT01311232 2017-10-27
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
Samsung Medical Center
Completed
NCT01580202 2017-06-29
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine
Seoul National University Hospital
Phase 3 Completed
NCT00888407 2017-05-30
Community-based Hepatitis B Interventions for Hmong Adults
University of California, Davis
Phase NA Completed
NCT00322361 2017-03-16
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01765231 2017-01-10
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Peking University
Phase 4 Unknown
NCT01768195 2017-01-10
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Peking University
Phase 4 Unknown
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT00760721 2016-11-28
Increasing Hepatitis B Screening Among Korean Church Attendees
University of California, Los Angeles
Phase 3 Completed
NCT00767936 2016-06-29
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
Terminated